Osaka, Japan

Takeshi Yamauchi


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Takeshi Yamauchi

Introduction

Takeshi Yamauchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of interferon inducers. His work has implications for medical treatments and therapies, showcasing the importance of innovation in healthcare.

Latest Patents

Yamauchi holds a patent for an "Interferon inducer and method of preparing same." This invention involves double-stranded RNA synthesized using native human DNA as a template. It has been found to be an excellent interferon inducer with low toxicity, despite being homologous to the native host cell. The process includes reacting ATP, GTP, CTP, and UTP in the presence of native human DNA, facilitated by the catalytic action of an active RNA polymerase. The resulting RNA is then subjected to annealing through heating and gradual cooling to form double-stranded regions.

Career Highlights

Yamauchi is associated with The Green Cross Corporation, where he continues to advance his research and innovations. His work has garnered attention for its potential applications in therapeutic settings, particularly in enhancing immune responses.

Collaborations

Some of his notable coworkers include Hirofumi Arimura and Masanori Nagai. Their collaborative efforts contribute to the ongoing research and development in the field of biotechnology.

Conclusion

Takeshi Yamauchi's contributions to the field of biotechnology, particularly through his patent on interferon inducers, highlight the critical role of innovation in advancing medical science. His work exemplifies the impact that dedicated inventors can have on healthcare and therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…